Cambridge biotech’s plan to merge with Trump commerce secretary’s SPAC falls apart


A Cambridge biotech's plan to merge with a special-purpose acquisition company, or SPAC, sponsored by the former U.S. commerce secretary under President Donald Trump has fallen apart.

Previous Greensboro developer Signature Property Group starts on 360-unit apartment project in Monroe
Next Business Journal's 2023 class of 10 Health Care Heroes honored for tireless work in the Valley